Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.12 | 17.28 |
| PEG Ratio (TTM) | 0.99 | 1.51 |
| P/S Ratio (TTM) | 1.18 | 2.83 |
| P/B Ratio (TTM) | 2.32 | 1.85 |
| P/FCF Ratio (TTM) | 1.75 | -1.96 |
| Price to 5YR AVG Earnings Ratio | 7.57 | 7.35 |
| Price to 5YR AVG FCF Ratio | 3.02 | -120.27 |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.35% | -1.84% |
| ROE (TTM) | 14.64% | 8.21% |
| Net Profit Margin (TTM) | 7.89% | 15.97% |
| ROIC 5YR AVG | 18.50% | 9.73% |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 336.45% | 318.98% | 170.46% |
| Revenue | 7.79% | 26.65% | 10.83% |
| Net Income | 344.97% | 339.61% | 181.16% |
| Cash Flow | 209.08% | 154.22% | 117.88% |
Health (44%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.09 | 2.49 |
| Quick Ratio (TTM) | 1.09 | 2.80 |
| D/E Ratio (TTM) | 2.38 | 3.63 |
| Interest Coverage (TTM) | 1.78 | 1.01 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 0.61 | 0.96 |
| LTL to 5YR AVG FCF | 1.85 | -218.70 |
| Shares Outstanding Growth 5YR AVG | -0.95% | 2.03% |